checkAd
    Startseite > Nachrichten > Analysen > Nachricht

     113  0 Kommentare Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering - Seite 3

    CONTACT:
    Miriam Weber Miller
    Aptevo Therapeutics
    Email: IR@apvo.com or Millerm@apvo.com
    Phone: 206-859-6628

    Lesen Sie auch

    SOURCE: Aptevo Therapeutics



    View the original press release on accesswire.com


    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3
    Verfasst von Accesswire
    Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering - Seite 3 SEATTLE, WA / ACCESSWIRE / April 15, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR and ADAPTIR-FLEX platform …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer